Nora Eccles Harrison Cardiovascular Research & Training Institute

Muscle Biology and Heart Failure

CVRTI’s Research on Heart Failure & Heart Biology

Heart failure is a clinical condition that results from an inability of the heart to pump blood efficiently.  Patients with Heart failure are often subdivided by those with hearts that do not contract well (which is Heart Failure with reduced Ejection Fraction or HFrEF) and those with hearts that do not relax well in between contraction (which is Heart Failure with preserved Ejection Fraction, or HFpEF).  Combined, there are 6 to 8 million Americans with heart failure, which has a high incidence of sickness (morbidity) and death (mortality).  Additionally, the economic consequences of heart failure are devastating.  Heart Failure related hospitalizations are a primary driver of our national Medicare and healthcare budget. 

At the CVRTI, Investigators are researching the mechanistic basis of heart failure focusing on studies in muscle biology. Our central hypothesis is that the more we learn about how heart muscle cells fail, the greater the chance we will be able to develop novel diagnostics and therapeutics for this devastating disease.  Our efforts are already having success.  Our investigators have developed novel blood-based diagnostics of failing heart muscle and have developed protocols for rescuing failing muscle on mechanical devices that can avoid future heart transplants and develop new gene therapies for failing heart muscle.  Our ambitious goal is to change how heart failure is diagnosed and treated for the millions of patients who suffer from this disease.

Publications & Research

Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, with Heart Failure with Preserved Ejection Fraction and Cardiovascular Hospitalization. 

                  This study introduces a novel, first in class, biomarker of heart failure. For a subset of patients who have heart failure with preserved ejection fraction (HFpEF), the                   biomarker (CS) recognizes heart remodeling and can predict which patients will suffer from future clinical                   decompensation.https://jamanetwork.com/journals/jamacardiology/fullarticle/2711896  

                    Nikolova AP, Hitzeman TC, Baum R, Caldaruse A, Agvanian S, Xie Y, Geft DR, Chang DH, Moriguchi JD, Hage A, Azarbal B, Czer LS, Kittleson MM, Patel JK, Wu AHB, Kobashigawa JA,                     Hamilton M, Hong Thttps://cvrti.utah.edu/the-hong-laboratory/T, Shaw RM.  Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection fraction and                     cardiovascular hospitalization. JAMA Cardiology, 2018; 3:1206-1210. 

Auxiliary Trafficking Subunit GJA1-20k Protects Connexin43 from Degradation and Limits Ventricular Arrhythmias.

                  This study introduces how a protein formed by internal translation of Connexin43 mRNA is essential for the electrical communication of each heartbeat. Without it,                   arrhythmias and sudden death occur. In a broader sense, the study explains how previously unknown proteins are generated and required for heart function,                   expanding our body’s repertoire of protein diversity.  https://www.jci.org/articles/view/134682

                    Xiao S, Shimura D, Baum R, Hernandez DM, Agvanian S, Nagaoka Y, Katsumata M, Lampe PD, Kleber AG, Hong T, Shaw RM. Auxiliary Trafficking Subunit GJA1-20k Protects Connexin43                     from Degradation and Limits Ventricular Arrhythmias. JCI, 2020; 130(9):4858-4870.

Cardiac BIN1 Folds T-tubule Membrane, Controlling Ion Flux and Limiting Arrhythmia. 

                  This study introduces a new concept of how heart muscle is organized and identifies a new cardiac protein (cardiac BIN1 or cBIN1), which is responsible for the                   microarchitecture of heart muscle cells. cBIN1 is important as both a diagnostic for patients with heart failure, and therapeutic for patients with either heart failure                   with reduced ejection fraction (HFrEF) or heart failure with preserved ejection fraction (HFpEF). https://www.nature.com/articles/nm.3543

                    Hong T, Yang H, Zhang S, Cho HC, Kalashnikova M, Sun B, Zhang H, Bhargava A, Grabe M, Olgin J, Gorelik J, Marbán E, Jan LY, Shaw RM. Cardiac BIN1 folds T-tubule membrane,                     controlling ion flux and limiting arrhythmia. Nature Medicine, 2014; 20:624-32.

Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning. 

                  This study discovered mechanical unloading induced up-regulation of glycolytic metabolites without a subsequent increase in pyruvate oxidation through the                   tricarboxylic acid (TCA) cycle. This investigation also demonstrated the effects of mechanical unloading on myocardial energetics, mitochondrial biogenesis,                   structure, and function.  https://www.sciencedirect.com/science/article/pii/S2452302X16301097 

                  Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Miller DV, Park SY, Richardson RS, Deberardinis R, Cox JE, Kfoury AG, Selzman CH, Stehlik J, Fang JC,                   Li DY, Drakos SG. Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for                   Cardiac Reloading and Conditioning. JACC Basic Transl Sci, 2016; 1(6):432-444.

Identification of Nodal Tissue in the Living Heart Using Rapid Scanning Fiber-Optics Confocal Microscopy and Extracellular Fluorophores. 

                  This study demonstrates feasibility of identifying nodal tissue in living heart using extracellular fluorophores and fiber-optics confocal microscopy. Application of the                   approach in pediatric reconstructive heart surgery may reduce risks of injuring nodal tissues. https://www.ahajournals.org/doi/full/10.1161/circimaging.112.000121

                    Huang C, Kaza AK, Hitchcock RW, Sachse FB. Identification of nodal tissue in the living heart using rapid scanning fiber-optics confocal microscopy and extracellular fluorophores.                    Circulation: Cardiovascular Imaging, 2013; 6(5), 739-746.

In Mice Subjected to Chronic Stress, Exogenous cBIN1 Preserves Calcium-Handling Machinery and Cardiac Function. 

                   This study introduces the role of cBIN1-microdomains in organizing intracellular distribution of SERCA2a, which is disrupted in chronically stressed hearts with                    diastolic dysfunction. By normalizing cBIN1-microdomain via gene therapy, intracellular distribution of dyads and SERCA2a is reorganized to improve cardiac                    inotropy and lusitropy of failing hearts. https://www.sciencedirect.com/science/article/pii/S2452302X20301212?via%3Dihub

                     Liu Y, Zhou K, Li J, Agvanian S, Caldaruse AM, Shaw S, Hitzeman TC, Shaw RM, Hong T. In Mice Subjected to Chronic Stress, Exogenous cBIN1 Preserves Calcium-Handling Machinery                      and Cardiac Function. JACC Basic Transl Sci, 2020; 5(6), 561-578.

Isoproterenol Promotes Rapid Ryanodine Receptor Movement to Bridging Integrator 1 (BIN1)-Organized Dyads. 

                     This study introduces the role of cBIN1-microdomains in organizing L-type calcium channel and ryanodine receptor couplons at dyads. The study also identifies                      the super dynamic feature of cBIN1-microdomains, which reorganize within 5 minutes of beta-adrenergic activation for efficient excitation-contraction coupling                      during an acute stress response. https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.115.018535 

                       Fu Y, Shaw SA, Naami R, Vuong CL, Basheer WA, Guo X, Hong T. Isoproterenol Promotes Rapid Ryanodine Receptor Movement to Bridging Integrator 1 (BIN1)-Organized Dyads.                        Circulation, 2016; 133(4), 388-97.

Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart: Implications for Ventricular Assist Devices-Induced Cardiac Recovery. 

                      This study was the first to produce molecular, metabolic, histological, ultrastructural/EM, microstructural and functional data disproving the widely held view that                       chronic mechanical unloading leads to disuse myocardial atrophy that inhibits myocardial recovery.                       https://www.sciencedirect.com/science/article/pii/S0735109714057751 

                         Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Reid BB, Miller DV, Salama ME, Fang JC, Drakos SG. Myocardial atrophy and chronic mechanical unloading of the failing                          human heart: implications for ventricular assist devices-induced cardiac recovery. J Am Coll Cardiol, 2014; 64:1602-12. 

Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional recovery by Mechanical Unloading. 

                       This study revealed that the transverse tubular system (t-system) in end-stage human heart failure presents a characteristic novel phenotype consisting of                        sheet-like invaginations of the sarcolemma. Our results suggest that the remodeled t-system impairs excitation-contraction coupling and functional recovery                        during chronic left ventricular assist device (LVAD) unloading. An intact t-system at the time of LVAD implantation may constitute a precondition and predictor for                        functional cardiac recovery after mechanical unloading. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.116.024470

 

                         Seidel T, Navankasattusas S, Ahmad A, Diakos NA, Xu WD, Tristani-Firouzi M, Bonios MJ, Taleb I, Li DY, Selzman CH, Drakos SG, Sachse FB. Sheet-like remodeling of the                          transverse tubular system in human heart failure impairs excitation-contraction coupling and functional recovery by mechanical unloading. Circulation, 2017; 25;135(17):1632                          45.

Subcellular Structures and Function of Myocytes Impaired During Heart Failure are Restored by Cardiac Resynchronization Therapy. 

                       This study demonstrates remodeling of the transverse tubular system (t-system) and the spatial association of ryanodine receptor (RyR) clusters in a canine                        model of dyssynchronous heart failure. After CRT, we found a remarkable and almost complete reverse remodeling of these structures despite persistent left                        ventricular dysfunction. Studies of whole-cell calcium transients showed that the structural remodeling and restoration were accompanied with remodeling and                        restoration of calcium signaling. https://www.ahajournals.org/doi/full/10.1161/circresaha.111.257428 

                         Sachse FB, Torres NS, Savio-Galimberti E, Aiba T, Kass DA, Tomaselli GF, Bridge JH. Subcellular structures and function of myocytes impaired during heart failure are restored by                          cardiac resynchronization therapy. Circulation Research, 2012; 110(4), 588-597.

The ESCRT-III Pathway Facilitates Cardiomyocyte Release of cBIN1-Containing Microparticles. 

                       This study introduces the mechanistic turnover of cardiomyocyte cBIN1-microdomains from normal and failing cardiomyocytes. cBIN1 interacts with an ESCRT-III                        member CHMP4B to release cBIN1-microparticles from cardiomyocyte membrane microdomains into circulation. The released cBIN1-microparticles carry                        cardiac specific signals serving as a marker of biochemical health of cardiomyocytes. https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2002354

                         Xu B, Fu Y, Liu Y, Agvanian S, Wirka RC, Baum R, Zhou K, Shaw RM, Hong T. The ESCRT-III pathway facilitates cardiomyocyte release of cBIN1-containing microparticles. PLoS Biol,                          2017; 15(8), e2002354.

The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. 

                       Based on the previous study in JACC Basic Translational Science by Badolia et. al, we hypothesized that the accumulated glycolytic intermediates are channeled                        into accessory pathways of glucose metabolism that are cardioprotective and may induce myocardial recovery. In this follow-up study, we discovered that the                        recovering heart directs glycolytic metabolites into nonglycolytic glucose metabolism pathways such as pentose-phosphate and 1-carbon metabolism, which                        contributed to cardioprotection and myocardial repair by generating reduced NADP, enhancing biosynthesis and reducing oxidative stress. These discoveries                        provide insights into novel therapeutic targets for myocardial recovery. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.044452 

                         Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Navankasattusas S, Wever-Pinzon O, Selzman CH, Chaudhuri D, Rutter J, Drakos SG. The Role of Nonglycolytic                          Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 2020; 142(3):259-274. 

Cardiac Research Labs

Drakos Laboratory

The Drakos Laboratory, headed by Stavros Drakos, MD, PhD, focuses on understanding the metabolic and molecular profile of the failing and recovered heart and utilizes biological information derived from studies in humans, small, and large animal HF models to understand, predict and manipulate myocardial recovery. Original work generated by the Drakos research team in the laboratory and in the clinical arena led to the founding and establishment of the award winning multidisciplinary Utah Cardiac Recovery Program (UCAR). Link to lab summary page on CVRTI

Hong Laboratory

The Hong Laboratory, headed by TingTing Hong, MD, PhD, studies the regulation and remodeling of membrane microdomains of cardiomyocytes during heart failure progression. They study how cardiomyocyte surface microdomains are organized to concentrate ion channels and signaling proteins for proper function and regulation in normal and failing hearts. The research includes the mechanisms of scaffolding protein and cytoskeleton-based maintenance of membrane structures and subdomains important in calcium signaling, turnover mechanisms of microdomains, and the mechanisms of heart failure progression. The Hong lab’s goal is to identify, at the bench, new molecular and cellular targets that can be translated to develop new therapeutic tools for clinical management of heart failure.

Sachse Laboratory 

The Sachse Laboratory, headed by Frank Sachse, PhD, provides insights into structural and functional remodeling in diseased hearts and mechanisms of cardiac recovery after clinical therapy. They also develop optical approaches to support pediatric heart surgery and interventional cardiology.

Shaw Laboratory

The Shaw Laboratory, headed by Robin Shaw, MD, PhD, is focused on understanding the cell biology of heart arrhythmias and heart failure progression. Link to lab summary page on CVRTI The Shaw Laboratory, headed by Robin Shaw, MD, PhD, is focused on understanding the cell biology of heart arrhythmias and heart failure progression. Link to lab summary page on CVRTI